tirzepatide in burbank (Mounjaro) Sherman Oaks Tirzepatide (Mounjaro) In Sherman Oaks

- - - A new Oxford meta-analysis (P04.009, EASO 2025) confirms what many clinicians have observed: stopping GLP-1 receptor agonists often leads to rapid and near-complete weight regain within 12 years

They agreed semaglutide may be better for weight loss.

Diabetes leads to a significantly accelerated incidence of various related macrovascular complications, including peripheral vascular disease and cardiovascular disease (the most common cause of mortality in diabetes), as well as microvascular complications such as kidney disease and retinopathy

Even if you are not taking Semaglutide, this panel can provide valuable information about your blood sugar and insulin levels, kidney and liver function, thyroid health, blood count, cholesterol, and vitamin B12

Simple Comparison between upcoming Monthly GLP-1s: By Amgen and Pfizer The Monthly Obesity Treatment Race Is Heating Up The next wave of obesity pharmacotherapy may not be about achieving greater efficacy aloneit may also be about achieving it with less frequent dosing